02. Chamber Enlargement and Vectorial Hypertrophy Criteria
Adult chamber hypertrophy reflects chronic pressure overload (concentric hypertrophy) or volume overload (eccentric dilatation) resulting from systemic hypertension, valvular heart disease, or cardiomyopathies.
1. Atrial Enlargement & Interatrial Conduction Blocks
| Condition | Lead II Electrocardiographic Criteria | Lead $V_1$ Electrocardiographic Criteria | Clinical Significance |
|---|---|---|---|
| Right Atrial Enlargement (RAE / P-Pulmonale) | Tall peaked P wave $> 2.5\text{ mm } (0.25\text{ mV})$. | Positive deflection of P wave $> 1.5\text{ mm}$. | COPD, Pulmonary Embolism, Tricuspid regurgitation, Pulmonary Hypertension. |
| Left Atrial Enlargement (LAE / P-Mitrale) | Broad, notched P wave duration $\ge 0.12\text{ s}$ with inter-peak notch $>0.04\text{ s}$. | Deep terminal negative component $> 1\text{ mm}$ deep and $> 0.04\text{ s}$ wide (Morris Index). | Mitral stenosis, severe systemic hypertension, LV diastolic dysfunction. |
| Interatrial Block (Bayés Syndrome) | P-wave duration $\ge 120\text{ ms}$ with biphasic (+/-) morphology in inferior leads (II, III, aVF). | Biphasic P wave with terminal negativity. | Conduction delay across Bachmann's Bundle; powerful predictor of paroxysmal Atrial Fibrillation and cardioembolic stroke. |
2. Left Ventricular Hypertrophy (LVH) Criteria
| Diagnostic Voltage / Point System | Quantitative Electrocardiographic Criteria | Diagnostic Sensitivity & Specificity |
|---|---|---|
| Cornell Voltage-Duration Product | $(R_{aVL} + S_{V3}) \times QRS\text{ duration} > 2440\text{ mm}\cdot\text{ms}$ (in women add $8\text{ mm}$ to $R_{aVL}$ amplitude). | Highest sensitivity ($\sim 40\%$) with high specificity ($>95\%$). |
| Sokolow-Lyon Index | $S_{V1} + R_{V5} \text{ or } R_{V6} \ge 35\text{ mm}$, or $R_{aVL} \ge 11\text{ mm}$. | Specificity $98\%$, but sensitivity $<25\%$. |
| Romhilt-Estes Point Score | Score $\ge 5$ = Definite LVH; Score $4$ = Probable LVH. - Amplitude ($R/S$ in limb leads $\ge 20\text{ mm}$ or $S_{V1/V2} \ge 30\text{ mm}$): 3 pts - ST-T strain pattern (without digitalis): 3 pts - Left atrial enlargement (Morris index): 3 pts - Left axis deviation ($\le -30^\circ$): 2 pts - QRS duration $\ge 90\text{ ms}$: 1 pt - Intrinsicoid deflection in $V_5-V_6 \ge 50\text{ ms}$: 1 pt | Comprehensive multi-parametric score. |
3. Right Ventricular Hypertrophy (RVH)
- Myers & Sokolow Criteria:
- $R/S$ ratio in lead $V_1 > 1.0$.
- $R$ wave in $V_1 \ge 7\text{ mm}$.
- $S$ wave in $V_5$ or $V_6 \ge 7\text{ mm}$.
- Right Axis Deviation ($>+90^\circ$).
- Right Ventricular Strain Pattern (ST depression and T-wave inversion in $V_1 - V_3$).
4. Multimodality Diagnostic Investigations
- Transthoracic Echocardiography (TTE): Calculates Left Ventricular Mass Index (LVMI: LVH defined as $>115\text{ g/m}^2$ in men, $>95\text{ g/m}^2$ in women) and Relative Wall Thickness (RWT: $>0.42$ defines concentric hypertrophy).
- Cardiac MRI: Most accurate standard for volumetric myocardial mass quantification.
5. Evidence-Based Clinical Management Protocols
- Intensive Antihypertensive Therapy: Angiotensin Receptor Blockers (ARBs) and ACE inhibitors promote the greatest degree of LVH electrocardiographic and anatomical regression.
- Anticoagulation in Bayés Syndrome: Prophylactic oral anticoagulation (DOACs) considered in advanced interatrial block with high CHA2DS2-VASc scores to prevent embolic stroke.